IVP
MRNA icon

Intrinsic Value Partners’s Moderna MRNA Stock Holding History

Intrinsic Value Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$577K Sell
8,244
-670
-8% -$34.7K 0.39% 49
2026
Q1 		$453K Sell
8,914
-4,230
-32% -$197K 0.35% 52
2025
Q4 		$388K Sell
13,144
-6,404
-33% -$174K 0.29% 58
2025
Q3 		$505K Sell
19,548
-9,243
-32% -$258K 0.41% 45
2025
Q2 		$794K Sell
28,791
-7,420
-20% -$195K 0.71% 33
2025
Q1 		$1.03M Sell
36,211
-44
-0.1% -$1.56K 1.01% 23
2024
Q4 		$1.51M Sell
36,255
-15,137
-29% -$723K 1.51% 18
2024
Q3 		$3.43M Buy
51,392
+24,505
+91% +$2.25M 3.44% 9
2024
Q2 		$3.19M Sell
26,887
-25
-0.1% -$3.16K 3.33% 10
2024
Q1 		$2.87M Sell
26,912
-459
-2% -$46.3K 3.06% 11
2023
Q4 		$2.72M Buy
27,371
+6,760
+33% +$569K 3.17% 9
2023
Q3 		$2.13M Buy
20,611
+5,600
+37% +$625K 2.74% 12
2023
Q2 		$1.82M Buy
15,011
+3,051
+26% +$407K 2.3% 13
2023
Q1 		$1.84M Sell
11,960
-560
-4% -$92.4K 2.48% 13
2022
Q4 		$2.25M Sell
12,520
-1,330
-10% -$217K 3.08% 10
2022
Q3 		$1.64M Buy
13,850
+3,715
+37% +$564K 2.28% 14
2022
Q2 		$1.45M Buy
+10,135
New +$1.45M 1.85% 16

Other funds holding MRNA

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
RA
REX Advisers Fairfield, Connecticut $44.3M AUM

Intrinsic Value Partners's MRNA Position: Q2 2026 in Review

Intrinsic Value Partners reduced its Moderna (MRNA) stake by 7.5% in Q2 2026, selling an estimated $34.7K and leaving 8,244 shares worth $577K. The position accounts for 0.39% of the portfolio, ranked #49.

Intrinsic Value Partners first reported a position in MRNA in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.43M in Q3 2024. 99 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Intrinsic Value Partners held 8,244 shares of Moderna worth $577K as of Q2 2026.
  • Intrinsic Value Partners sold 670 Moderna shares in Q2 2026, an estimated $34.7K.
  • Moderna made up 0.39% of Intrinsic Value Partners's portfolio in Q2 2026, its #49 holding.
  • Intrinsic Value Partners first reported a position in Moderna in Q2 2022 and has held it in 17 quarters since.
  • Intrinsic Value Partners's Moderna position peaked at $3.43M in Q3 2024.
  • 99 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Intrinsic Value Partners's 13F filing for Q2 2026, filed 14 Jul 2026.